NCT03572647 - Pharmacokinetics and Pharmacodynamics Assessment of Drug Eritromax Compared to Eprex in Healthy Subjects. | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

May 31, 2013

Conditions

Renal Insufficiency, Chronic

Interventions

DRUG

Eritromax

The subjects will receive a single dose of 4000 IU epoetin alfa in each period, according to randomisation.

DRUG

Eprex

The subjects will receive a single dose of 4000 IU epoetin alfa in each period, according to randomisation.

Trial Locations (1)

LAL Clínica Pesquisa e Desenvolvimento Ltda., Valinhos